AEG-1 promotes anoikis resistance and orientation chemotaxis in hepatocellular carcinoma cells

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Zhou, Zhenzhen ^a   Deng, Huan ^a   Yan, Wei ^a   Luo, Min ^a   Tu, Wei ^a   Xia, Yujia ^a   He, Jiayi ^a   Han, Ping ^a   Fu, Yu ^a   Tian, De'an ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; CHEMOKINE RECEPTOR CXCR4; PHOSPHATIDYLINOSITOL 3 KINASE; PLERIXAFOR; PROTEIN BAD; PROTEIN BCL 2; PROTEIN KINASE B; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; BAD PROTEIN, HUMAN; BCL2 PROTEIN, HUMAN; CELL ADHESION MOLECULE; CHROMONE DERIVATIVE; CULTURE MEDIUM; HETEROCYCLIC COMPOUND; MORPHOLINE DERIVATIVE; MTDH PROTEIN, HUMAN;

ANOIKIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CHEMOTAXIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENETIC TRANSFECTION; HCC LM3 CELL LINE; HUMAN; HUMAN CELL; LIVER CANCER CELL LINE; LIVER CELL CARCINOMA; LUNG ALVEOLUS CELL; METASTASIS; MHCC 97H CELL LINE; MICROVASCULAR ENDOTHELIAL CELL; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE AEG 1; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SMMC 7721 CELL LINE; SUPERNATANT; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL ADHESION; CELL SURVIVAL; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; LIVER CELL; METABOLISM; PATHOLOGY; PHARMACOLOGY; PHOSPHORYLATION; SECRETION (PROCESS); TUMOR CELL LINE;

ANOIKIS; BCL-ASSOCIATED DEATH PROTEIN; CELL ADHESION; CELL ADHESION MOLECULES; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOKINE CXCL12; CHEMOTAXIS; CHROMONES; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HETEROCYCLIC COMPOUNDS; HUMANS; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CXCR4; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84903312447     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100372     Document Type: Article

References (65)

1. Yang JD, Roberts LR (2010) Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 7: 448-458.
2. Gupta GP, Massagué J (2006) Cancer metastasis: building a framework. Cell 127: 679-695. (Pubitemid 44781029)
3. Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147: 275-292.
4. Mundy GR (1997) Mechanisms of bone metastasis. Cancer 80: 1546-1556.
5. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572. (Pubitemid 37328923)
6. Fidler IJ (2002) Critical determinants of metastasis. Semin Cancer Biol 12: 89-96.
7. Woodhouse EC, Chuaqui RF, Liotta LA (1997) General mechanisms of metastasis. Cancer 80: 1529-1537. (Pubitemid 27444024)
8. Boyce BF, Yoneda T, Guise TA (1999) Factors regulating the growth of metastatic cancer in bone. Endocr Relat Cancer 6: 333-347. (Pubitemid 29459783)
9. Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-593.
10. Katyal S, Oliver JH 3rd, Peterson MS, Ferris JV, Carr BS, et al. (2000) Extrahepatic metastases of hepatocellular carcinoma. Radiology 216: 698-703. (Pubitemid 30660840)
11. Frisch SM, Francis H (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626. (Pubitemid 24064472)
12. Azab AK, Runnels JM, Pitsillides C, Moreau AS, Azab F, et al. (2009) CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood 113: 4341-4351.
13. Brown DM, Ruoslahti E (2004) Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 5: 365-374. (Pubitemid 38482072)
14. Liu L, Wu J, Ying Z, Chen B, Han A, et al. (2010) Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer 70: 3750-3759.
15. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, et al. (2007) Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 26: 7647-7655. (Pubitemid 350224215)
16. Yoo BK, Emdad L, Su ZZ, Villanueva A, Chiang DY, et al. (2009) Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 119: 465-477.
17. Yu C, Chen K, Zheng H, Guo X, Jia W, et al. (2009) Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 30: 894-901.
18. Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao W, et al. (2002) Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 21: 3592-3602. (Pubitemid 34587691)
19. Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ, et al. (2005) Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 353: 8-15. (Pubitemid 40805356)
20. Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, et al. (2008) Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 27: 1114-1121. (Pubitemid 351253177)
21. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, et al. (2009) MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer. Cancer Cell 15: 9-20.
22. Zhou Z, Deng H, Yan W, Huang H, Deng Y, et al. (2012) Expression of metadherin/AEG-1 gene is positively related to orientation chemotaxis and adhesion of human hepatocellular carcinoma cell lines of different metastatic potentials. J Huazhong Univ Sci Technolog Med Sci 32: 353-357.
23. Mawji IA, Simpson CD, Hurren R, Gronda M, Williams MA, et al. (2007) Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation. J Natl Cancer Inst 99: 811-822. (Pubitemid 47073526)
24. Simpson CD, Anyiwe K, Schimmer AD (2008) Anoikis resistance and tumor metastasis. Cancer Lett 272: 177-185.
25. Boisvert-Adamo K, Aplin AE (2006) B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis. Oncogene 25: 4848-4856. (Pubitemid 44201176)
26. Jost M, Huggett TM, Kari C, Rodeck U (2001) Matrix-independent survival of human keratinocytes through an EGF receptor/MAPK-kinase-dependent pathway. Mol Biol Cell 12: 1519-1527. (Pubitemid 33044429)
27. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, et al. (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430: 1034-1039.
28. Lu Y, Lin YZ, LaPushin R, Cuevas B, Fang X, et al. (1999) The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 18: 7034-7045. (Pubitemid 30028874)
29. Chen J, Li T, Wu Y, He L, Zhang L, et al. (2011) Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma:a meta-analysis. J Cancer Res Clin Oncol 137: 1799-1812.
30. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715. (Pubitemid 351636299)
31. Fung C, Lock R, Gao S, Salas E, Debnath J (2008) Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol Biol Cell 19: 797-806. (Pubitemid 351481798)
32. Loza-Coll MA, Perera S, Shi W, Filmus J (2005) A transient increase in the activity of Src-family kinases induced by cell detachment delays anoikis of intestinal epithelial cells. Oncogene 24: 1727-1737. (Pubitemid 40461129)
33. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, et al. (2002) Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62: 1832-1837. (Pubitemid 34408510)
34. Lee BC, Lee TH, Avraham S, Avraham HK (2004) Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2: 327-338. (Pubitemid 39025295)
35. Cabioglu N, Sahin A, Doucet M, Yavuz E, Igci A, et al. (2005) Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow. Clin Exp Metastasis 22: 39-46. (Pubitemid 41185860)
36. Kochetkova M, Kumar S, McColl SR (2009) Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells. Cell Death Differ 16: 664-673.
37. Wendt MK, Drury LJ, Vongsa RA, Dwinell MB (2008) Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cells. Gastroenterology 135: 508-517.
38. Frisch SM (1999) Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis. Curr Biol 9: 1047-1049.
39. Cabioglu N, Summy J, Miller C, Parikh NU, Sahin AA, et al. (2005) CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res 65: 6493-6497. (Pubitemid 41060680)
40. Pattarozzi A, Gatti M, Barbieri F, Würth R, Porcile C, et al. (2008) 17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment. Mol Pharmacol 73: 191-202. (Pubitemid 350294210)
41. Frisch SM, Ruoslahti E (1997) Integrins and anoikis. Curr Opin Cell Biol 9: 701-706. (Pubitemid 27424927)
42. Frisch SM, Screaton RA (2001) Anoikis mechanisims. Curr Opin Cell Biol 13: 555-562.
43. Hanahan D,Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
44. Chiarugi P, Giannoni E (2008) Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol 76: 1352-1364.
45. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, et al. (1995) Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285-291.
46. Kang H, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG (2005) The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. Breast 14: 360-367. (Pubitemid 41510192)
47. Uchida D, Begum NM, Almofti A, Nakashiro K, Kawamata H, et al. (2003) Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res 290: 289-302. (Pubitemid 37272173)
48. Li JK, Yu L, Shen Y, Zhou LS, Wang YC, et al. (2008) Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. World J Gastroenterol 14: 2308-2313. (Pubitemid 351877599)
49. Kim YN, Koo KH, Sung JY, Yun UJ, Kim H (2012) Anoikis Resistance: An Essential Prerequisite for Tumor Metastasis. Int J Cell Biol 2012: 306879.
50. Emdad L, Sarkar D, Su ZZ, Randolph A, Boukerche H, et al. (2006) Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res 66: 1509-1516. (Pubitemid 43259932)
51. Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ, et al. (2008) Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res 68: 1478-1484. (Pubitemid 351346856)
52. McFall A, Ulkü A, Lambert QT, Kusa A, Rogers-Graham K, et al. (2001) Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase. Mol Cell Biol 21: 5488-5499. (Pubitemid 32702453)
53. Isakoff SJ, Engelman JA, Irie HY, Luo J, Brachmann SM, et al. (2005) Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Cancer Res 65: 10992-11000. (Pubitemid 41713369)
54. Jiang K, Sun J, Cheng J, Djeu JY, Wei S, et al. (2004) Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis. Mol Cell Biol 24: 5565-5576. (Pubitemid 38738186)
55. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285: 1028-1032.
56. Aplin AE, Howe AK, Juliano RL (1999) Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol 11: 737-744.
57. Dedhar S (2000) Cell-substrate interactions and signaling through ILK. Curr Opin Cell Biol 12: 250-256.
58. Lee SG, Su ZZ, Emdad L, Sarkar D, Fisher PB (2006) Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci USA 103: 17390-17395. (Pubitemid 44788979)
59. Pawlak G, Helfman DM (2001) Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 11: 41-47. (Pubitemid 32119276)
60. Kang HG, Jenabi JM, Zhang J, Keshelava N, Shimada H, et al. (2007) E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res 67: 3094-3105. (Pubitemid 46724846)
61. Derksen PW, Braumuller TM, van der Burg E, Hornsveld M, Mesman E, et al. (2011) Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice. Dis Model Mech 4: 347-358.
62. Britt DE, Yang DF, Yang DQ, Flanagan D, Callanan H, et al. (2004) Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Exp Cell Res 300: 134-148. (Pubitemid 39286223)
63. Hu G, Wei Y, Kang Y (2009) The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res 15: 5615-5620.
64. Alix-Panabières C, Riethdorf S, Pantel K (2008) Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res 14: 5013-5021.
65. Zlotnik A (2004) Chemokines in neoplastic progression. Semin Cancer Biol 14: 181-185.